Cargando…
Subcutaneous golimumab to treat a biological naïve chronically active ulcerative colitis child. A case report
INTRODUCTION: Ulcerative colitis is an immune-mediated disease that carries challenges in pediatrics since it's frequently severe and extensive. Current pediatric ulcerative colitis guidelines offer a weak recommendation regarding the usage and the dosage of golimumab in low-weight children. We...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977938/ https://www.ncbi.nlm.nih.gov/pubmed/35386809 http://dx.doi.org/10.1016/j.amsu.2022.103456 |